Jilin Province Huinan Changlong Bio-Pharmacy announces revised annual shareholder meeting notice

• Jilin Province Huinan Changlong Bio-Pharmacy will hold its annual general meeting in Huinan County, Jilin Province on June 9, 2026.
• Shareholders will vote on receiving audited 2025 financial statements, directors’ report, independent auditor’s report, and Supervisory Committee report.
• Items include reappointing Prism Hong Kong as auditor for 2026, setting remuneration for directors and supervisors, and electing directors and supervisors for a three-year term through 2029.
• The agenda also includes elections of additional executive directors and a supervisor, plus a mandate authorizing the board to allot and issue Domestic Shares or H Shares up to 20% of each class, subject to specified conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260513-12158022), on May 13, 2026, and is solely responsible for the information contained therein.